Month: <span>March 2025</span>
Month: March 2025

Maternal, fetal and neonatal outcomes among pregnant women with arthrogryposis multiplex congenita: a scoping review

Orphanet J Rare Dis. 2025 Mar 17;20(1):129. doi: 10.1186/s13023-025-03631-5. ABSTRACT BACKGROUND: The rarity of pregnancies in women with arthrogryposis multiplex congenita (AMC) could lead to …

The prevalence and risk factors of vaginal Candida species and group B Streptococcus colonization in pregnant women attending antenatal care at Hawassa university comprehensive specialized hospital in Hawassa City, Southern Ethiopia

BMC Pregnancy Childbirth. 2025 Mar 17;25(1):299. doi: 10.1186/s12884-025-07402-9. ABSTRACT BACKGROUND: The global prevalence of vaginal candidiasis and group B streptococcus (GBS) colonization among pregnant women …

Impact of continuous renal replacement therapy and Cytosorb on cefiderocol pharmacokinetics: “One size does not fit all”

Int J Artif Organs. 2025 Mar 18:3913988251322702. doi: 10.1177/03913988251322702. Online ahead of print. ABSTRACT Cefiderocol, a novel broad-spectrum cephalosporin, exhibits promising efficacy against carbapenem-resistant Gram-negative …

Cochlear implant procedure. Italian Clinical Practice Guidelines of the Italian Society of Otorhinolaryngology (SIOeChCF) and Italian Society of Audiology and Phoniatrics (SIAF). Part 1: cochlear implants in adults

Acta Otorhinolaryngol Ital. 2025 Feb;45(1):47-57. doi: 10.14639/0392-100X-N3081. ABSTRACT OBJECTIVE: Cochlear implant (CI) is a well-established treatment for adults with sensorineural hearing loss and without benefit …

Perioperative Management With Efanesoctocog Alfa in Patients With Haemophilia A in the Phase 3 XTEND-1 and XTEND-Kids Studies

Haemophilia. 2025 Mar 18. doi: 10.1111/hae.70017. Online ahead of print. ABSTRACT INTRODUCTION: The Phase 3 studies, XTEND-1 (NCT04161495) and XTEND-Kids (NCT04759131), showed once-weekly efanesoctocog alfa …